Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
1 Oxford University and Oxford Mental Healthcare Trust, Oxford
2 King's College London, Institute of Psychiatry, MRC Centre for Neurodegeneration Research, London SE5 8AF
3 Centre for Statistics in Medicine, Wolfson College, University of Oxford
4 Centre for the Health of the Elderly, University of Newcastle upon Tyne
5 Department of Psychiatry, University of Oxford
* Correspondence to: r.howard{at}iop.kcl.ac.uk.
Objective To evaluate the effectiveness of a training and support intervention for nursing home staff in reducing the proportion of residents with dementia who are prescribed neuroleptics.
Design Cluster randomised controlled trial with blinded assessment of outcome.
Setting 12 specialist nursing homes for people with dementia in London, Newcastle, and Oxford.
Participants Residents of the 12 nursing homes; numbers varied during the study period.
Intervention Training and support intervention delivered to nursing home staff over 10 months, focusing on alternatives to drugs for the management of agitated behaviour in dementia.
Main outcome measures Proportion of residents in each home who were prescribed neuroleptics and mean levels of agitated and disruptive behaviour (Cohen-Mansfield agitation inventory) in each home at 12 months.
Results At 12 months the proportion of residents taking neuroleptics in the intervention homes (23.0%) was significantly lower than that in the control homes (42.1%): average reduction in neuroleptic use 19.1% (95% confidence interval 0.5% to 37.7%). No significant differences were found in the levels of agitated or disruptive behaviour between intervention and control homes.
Conclusions Promotion of person centred care and good practice in the management of patients with dementia with behavioural symptoms provides an effective alternative to neuroleptics.
Read all Rapid Responses